Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05238103 · ClinicalTrials.gov registry record · NA
Impact of a Corrie Cardiac Rehabilitation Program
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 259
- Enrollment target
NCT05238103: Completed NA study, sponsored by Johns Hopkins University.
NCT05238103 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 259 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05238103, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 259 participants
- Enrollment target
Study Summary
In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who have recently been diagnosed with myocardial infarction, received a coronary stent, underwent heart surgery or catheter-based valve replacement, as compared to traditional, center-based cardiac rehabilitation.
Primary Outcome
Mean difference in 6 minute walk distance, between Intervention and Control groups, as measured at final study visit occurring at 12 weeks after randomization.
Interventions
- COMBINATION_PRODUCT Corrie Hybrid Cardiac Rehabilitation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2024-10-14 |
| Phase | NA |
What the finished NCT05238103 record still lists
NCT05238103 is an interventional study that assigns participants to a tested intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Corrie Hybrid Cardiac Rehabilitation Program is the first listed.
NCT05238103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05238103 about?
NCT05238103 is a clinical study titled "Impact of a Corrie Cardiac Rehabilitation Program". In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who h...
What is the current status of trial NCT05238103?
This trial is currently completed. It is a NA study. The enrollment target is 259 participants. The study started on 2023-04-03. Estimated completion is 2024-10-14.
What interventions are being tested in trial NCT05238103?
The interventions under investigation include: Corrie Hybrid Cardiac Rehabilitation Program (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05238103?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05238103's enrollment target sits among peer trials
259 400th of 2000 higher than 1,599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02361320 · 259 participants · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- NCT06797258 · 259 participants · NA
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
- NCT06990425 · 259 participants · NA
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
- NCT07399977 · 259 participants · NA
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI